Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on August 19, 2026

Aug. 19, 2026

Understanding the Potential Risks of Prescription Drug Affordability Boards and Upper Payment Limits

Indeterminate EIN Presswire

Aug. 19, 2026

COA Submits Patient-Centered Recommendations on Sen. Cassidy's 340B Reform Discussion Draft

Indeterminate EIN Presswire

Aug. 19, 2026

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 19, 2026

US Navy Veterans Lung Cancer & Mesothelioma Advocate Now Urges a US Navy Veteran with Mesothelioma or Lung Cancer to Call for Instant Access to The Nation's Top Attorneys for Much Better Compensation Results

Indeterminate EIN Presswire

Aug. 19, 2026

Picard Medical Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 19, 2026

Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

Indeterminate GlobeNewswire

Aug. 19, 2026

Solésence Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 19, 2026

MedPro Healthcare Staffing Names Laurie Reichert President, Domestic Staffing

Indeterminate GlobeNewswire

Aug. 19, 2026

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Indeterminate GlobeNewswire

Aug. 19, 2026

DNA X, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 19, 2026

Merit Medical Announces Global Operations Leadership Transition

Indeterminate GlobeNewswire

Aug. 19, 2026

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire

Aug. 19, 2026

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 19, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Edesa Biotech Announces Proposed Public Offering

Indeterminate GlobeNewswire

Aug. 19, 2026

FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device

Indeterminate GlobeNewswire

Aug. 19, 2026

Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity

Indeterminate GlobeNewswire

Aug. 19, 2026

What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online

Indeterminate GlobeNewswire